Liu Xin, Fu Cuiping, Hu Weiping, Hao Shengyu, Xie Liang, Wu Xu, Wang Jihong, Liu Zilong, Lin Qunying, Li Shanqun
Department of Pulmonary and Critical Care Medicine, Fujian Medical University Teaching Hospital, Fujian Provincial Geriatric Hospital, Fujian Provincial Hospital North Branch, Fuzhou, China; Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Department of Pulmonary Medicine, the First Hospital Affiliated to Soochow University, Suzhou, China.
Ann Palliat Med. 2021 Apr;10(4):3763-3782. doi: 10.21037/apm-20-940. Epub 2021 Apr 15.
The effectiveness of Tai Chi for chronic obstructive pulmonary disease (COPD) so far is unclear. The present systematic review aimed to determine the influence of Tai Chi among people with COPD.
We searched six electronic databases for relevant studies in September, 2019. The methods of standard meta-analysis were used for identifying relevant studies, quality appraisal, and synthesis. The primary outcomes were six-minute walking distance (6MWD), percentage predicted forced expiratory flow volume in the first second (%PredFEV1), and St. George's Respiratory Questionnaire (SGRQ) score.
A total of 23 studies including 1663 participants were included in the meta-analysis. The pooled data showed that the Tai Chi group was associated with a significant improvement in 6MWD [mean difference (MD) 40.83 m, 95% CI: 32.47 to 49.19], %PredFEV1 (MD 1.67%, 95% CI: 0.41 to 2.93), SGRQ score (MD -6.57, 95% CI: -10.17 to -2.98), and Chronic Respiratory Disease Questionnaire (CRQ) (MD 1.60, 95% CI: 0.89 to 2.30) relative to the blank control population. When compared with breathing exercises, the 6MWD was significantly enhanced with Tai Chi (MD 14.15 m, 95% CI: 3.76 to 24.53). Finally, when compared with breathing and walking exercises, Tai Chi was associated with a significant improvement in 6MWD (MD 7.68 m, 95% CI: 2.28 to 13.09 m) and SGRQ score (MD -6.31, 95% CI: -9.13 to -1.48).
Tai Chi may have the potential to reduce dyspnoea, enhance exercise capacity, and improve the quality of life in COPD patients. People with COPD may obtain benefit from practicing Tai Chi.
太极拳对慢性阻塞性肺疾病（COPD）的有效性目前尚不清楚。本系统评价旨在确定太极拳对COPD患者的影响。
2019年9月，我们在六个电子数据库中检索了相关研究。采用标准的荟萃分析方法来识别相关研究、进行质量评估和综合分析。主要结局指标为六分钟步行距离（6MWD）、第一秒用力呼气容积预测值百分比（%PredFEV1）以及圣乔治呼吸问卷（SGRQ）评分。
共有23项研究、1663名参与者纳入荟萃分析。汇总数据显示，与空白对照组相比，太极拳组在6MWD[平均差值（MD）40.83米，95%置信区间（CI）：32.47至49.19]、%PredFEV1（MD 1.67%，95%CI：0.41至2.93）、SGRQ评分（MD -6.57，95%CI：-10.17至-2.98）以及慢性呼吸系统疾病问卷（CRQ）（MD 1.60，95%CI：0.89至2.30）方面均有显著改善。与呼吸锻炼相比，太极拳可显著提高6MWD（MD 14.15米，95%CI：3.76至24.53）。最后，与呼吸和步行锻炼相比，太极拳在6MWD（MD 7.68米，95%CI：2.28至13.09米）和SGRQ评分（MD -6.31，95%CI：-9.13至-1.48）方面有显著改善。
太极拳可能具有减轻慢性阻塞性肺疾病患者呼吸困难、增强运动能力和改善生活质量的潜力。慢性阻塞性肺疾病患者可能从练习太极拳中获益。
